We mainly examined overall mortality and the risks of shock, septic shock, cardiogenic shock, hypovolemic shock, heart failure, and pulmonary edema in patients with sepsis with hypoalbuminemia following albumin supplementation. The gene discussed is ALB; the disease is heart failure.